Figures & data
Table 1 Cardiovascular safety studies with empagliflozin, dapagliflozin and canagliflozin in patients with type 2 diabetes mellitus
Register now or learn more
Open access
Table 1 Cardiovascular safety studies with empagliflozin, dapagliflozin and canagliflozin in patients with type 2 diabetes mellitus
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.